Literature DB >> 7947488

1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts.

J Dobak1, J Grzybowski, F T Liu, B Landon, M Dobke.   

Abstract

The effect of 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) on proliferation and collagen type I and type III production in cultured human fibroblasts was examined. Previous studies have identified receptors for the vitamin in human dermal fibroblasts, and have suggested the skin to be a target tissue. While many studies examining keratinocyte modulation by 1,25-(OH)2D3 have been undertaken, very few have been performed on dermal fibroblasts. Neonatal foreskin fibroblast cultures were examined for cell number, extracellular collagen accumulation, and collagen mRNA levels, after 5 days exposure to 1,25-(OH)2D3 at a concentration of 10(-7) M. The vitamin significantly suppressed (P < 0.01) the proliferation of fibroblasts cultured in the presence of serum. Day 5 cell culture supernatants showed a significant per cell increase in collagen type I (P < 0.05) and type III (P < 0.01) as measured by ELISA. Type I collagen production in exposed cells was 11.64 + 0.531 microgram/10(6) cell vs. 9.53 + 0.500 microgram/10(6) cells in unexposed cells. Type III collagen production was 0.601 + 0.012 microgram/10(6) cell in exposed cells and 0.247 + 0.008 microgram/10(6) cells in unexposed cells. mRNA levels were increased after a 4-day exposure to 10(-7) M 1,25-(OH)2D3 for both type I (2.5-5-fold) and type III (5.5-7.76-fold) collagen. These results suggest a novel effect of increased collagen production by dermal fibroblasts upon exposure to 1,25-(OH)2D3 that is independent of proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947488     DOI: 10.1016/0923-1811(94)90316-6

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  9 in total

Review 1.  Role of vitamin D and calcium signaling in epidermal wound healing.

Authors:  D D Bikle
Journal:  J Endocrinol Invest       Date:  2022-08-13       Impact factor: 5.467

2.  Prevalence of vitamin D deficiency in chronic liver disease.

Authors:  J Arteh; S Narra; S Nair
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

3.  The relationship between serum 25 hydroxy vitamin d levels and asthma in children.

Authors:  Soheila Alyasin; Tooba Momen; Sara Kashef; Abbass Alipour; Reza Amin
Journal:  Allergy Asthma Immunol Res       Date:  2011-07-13       Impact factor: 5.764

4.  Chronic obstructive pulmonary disease is associated with low levels of vitamin D.

Authors:  Louise Jeanette Pauline Persson; Marianne Aanerud; Pieter Sicco Hiemstra; Jon Andrew Hardie; Per Sigvald Bakke; Tomas Mikal Lind Eagan
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

5.  Correlation of severity of chronic obstructive pulmonary disease with serum vitamin-D level.

Authors:  Ummul Baneen; Sufia Naseem
Journal:  J Family Med Prim Care       Date:  2019-07

6.  Curcumins-rich curry diet and pulmonary function in Asian older adults.

Authors:  Tze Pin Ng; Mathew Niti; Keng Bee Yap; Wan Cheng Tan
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

7.  Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality--results from a 10-year prospective cohort study.

Authors:  Dennis Back Holmgaard; Lone Hagens Mygind; Ingrid Louise Titlestad; Hanne Madsen; Palle Bach Nielsen Fruekilde; Svend Stenvang Pedersen; C Pedersen
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

8.  Vitamin D status and cause-specific mortality: a general population study.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Charlotta Pisinger; Torben Jørgensen; Betina Heinsbæk Thuesen; Mogens Fenger; Allan Linneberg
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Vitamin D status and chronic obstructive pulmonary disease: a prospective general population study.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Betina Heinsbæk Thuesen; Charlotta Pisinger; Torben Jørgensen; Runa Vavia Fenger; Allan Linneberg
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.